Prostate News Archive
11-Oct-2008
Watson Wins U.S. Approval for New Prostate Treatment (Update1) (Bloomberg)
Oct. 8 (Bloomberg) -- Watson Pharmaceuticals Inc. won U.S. approval to sell a prostate enlargement treatment as the drugmaker expands beyond manufacturing generic medicines. A new study supports the prognostic value of the PCA3 prostate cancer marker (CNW Group via Yahoo! Finance)
DiagnoCure Inc. , a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, reported today that PCA3, the Company's highly specific prostate cancer marker, is featured in an important article in the November issue of the Journal of Urology. Prostate Cancer Awareness Week (RainbowNetwork.com)
Did you know that this week is prostate cancer awareness week? Probably not. Every year about 27,000 men are diagnosed with prostate cancer and every year about 10,000 men die from it. Rapaflo Approved for Enlarged Prostate (MedicineNet.com)
Title: Rapaflo Approved for Enlarged Prostate Category: Health News Created: 10/10/2008 2:00:00 AM Last Editorial Review: 10/10/2008 Do Prostate Drugs Harm Bones? (MedicineNet.com)
Title: Do prostate Drugs Harm Bones? Category: Health News Created: 10/8/2008 Last Editorial Review: 10/8/2008
Back to Prostate News Archive
